Fusion Pharmaceuticals Inc. (FUSN)

HEALTH CARE: PHARMACEUTICALS
SIC: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)

270 LONGWOOD ROAD SOUTH HAMILTON, ONTARIO, CANADA L8P 0A6

Fusion Pharmaceuticals Inc. operates as a biopharmaceutical company. The Company discovers and develops novel targeted alpha therapeutics (TAT) and radiopharmaceuticals for the diagnosis and treatment of chemotherapy resistant cancers. Fusion Pharmaceuticals serves health care sectors in Canada.

Data as of 2021-05-08 12:10:47 -0400
Market Cap376.064 Million Shares Outstanding42.445 Million Avg 30-day Volume23.345 Thousand
P/E Ratio Dividend Yield EPS
Price/Sales Debt to Equity EBITDA
Price to Book Value0.0 Forward PE-7.06 Enterprise Value
Total Cash Current Debt Gross Profit
BETA0.0 52-week High/Low19.0 / 8.09 Next Earnings Date2021-05-13 Price to Cash FLow (P/CF) -9999999.0
Data provided by IEX Cloud

Are you looking for this stock instead?

View SEC Filings from FUSN instead.
Q4 2020 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 3 2 50.0% 1 (0.06%) 1 (0.06%) 0.0%
Funds Holding: 36 27 33.33% 15 (0.9%) 15 (0.93%) 0.0%
13F shares: 27.213 Million 25.594 Million 6.32% 11.447 Million 11.953 Million -4.23%
% Ownership
New Positions: 12 4 200.0% 2 1 100.0%
Increased Positions 7 4 75.0% 2 1 100.0%
Closed Positions 3 27 -88.89% 2 15 -86.67%
Reduced Positions 8 8 0.0% 7 7 0.0%
Total Calls
Total Puts
PUT/CALL Ratio
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding FUSN (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding FUSN BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

BERGSTROM DONALD A

  • Director
0 2021-04-01 2

LEE PHILINA

  • Director
0 2021-02-11 2

O'LEARY JAMES J CHIEF MEDICAL OFFICER

  • Officer
0 2021-02-04 1

CROWLEY JOHN J CHIEF FINANCIAL OFFICER

  • Officer
0 2021-02-04 1

BURAK ERIC CHIEF SCIENTIFIC OFFICER

  • Officer
0 2021-02-04 1

VALLIANT JOHN CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
0 2021-02-04 1

ADAMS STREET PARTNERS LLC

  • 10% Owner
3,494,056 2020-12-24 2

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

BERGSTROM DONALD A - Director

2021-04-01 16:20:00 -0400 2021-04-01 A 34,000 a 34,000 direct

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
FUSION PHARMACEUTICALS INC FUSN 2021-05-10 22:15:04 UTC -13.7563 13.8063 600000
FUSION PHARMACEUTICALS INC FUSN 2021-05-10 21:45:02 UTC -13.6319 13.6819 600000
FUSION PHARMACEUTICALS INC FUSN 2021-05-10 21:15:02 UTC -13.6319 13.6819 600000
FUSION PHARMACEUTICALS INC FUSN 2021-05-10 20:45:03 UTC -13.5159 13.5659 600000
FUSION PHARMACEUTICALS INC FUSN 2021-05-10 20:15:03 UTC -13.5159 13.5659 600000
FUSION PHARMACEUTICALS INC FUSN 2021-05-10 19:45:03 UTC -13.5159 13.5659 600000
FUSION PHARMACEUTICALS INC FUSN 2021-05-10 19:15:03 UTC -13.5159 13.5659 600000
FUSION PHARMACEUTICALS INC FUSN 2021-05-10 18:45:03 UTC -13.3991 13.4491 600000
FUSION PHARMACEUTICALS INC FUSN 2021-05-10 18:15:03 UTC -13.3991 13.4491 600000
FUSION PHARMACEUTICALS INC FUSN 2021-05-10 17:45:02 UTC -13.3991 13.4491 600000
FUSION PHARMACEUTICALS INC FUSN 2021-05-10 17:15:03 UTC -13.3991 13.4491 600000
FUSION PHARMACEUTICALS INC FUSN 2021-05-10 16:45:03 UTC -13.3991 13.4491 600000
FUSION PHARMACEUTICALS INC FUSN 2021-05-10 16:15:03 UTC -13.3991 13.4491 600000
FUSION PHARMACEUTICALS INC FUSN 2021-05-10 15:45:03 UTC -13.3991 13.4491 600000
FUSION PHARMACEUTICALS INC FUSN 2021-05-10 15:15:03 UTC -13.3991 13.4491 600000
FUSION PHARMACEUTICALS INC FUSN 2021-05-10 14:45:04 UTC -14.5186 14.5686 600000
FUSION PHARMACEUTICALS INC FUSN 2021-05-10 14:15:04 UTC -14.5186 14.5686 600000
FUSION PHARMACEUTICALS INC FUSN 2021-05-10 13:45:04 UTC -14.5186 14.5686 600000
FUSION PHARMACEUTICALS INC FUSN 2021-05-10 13:15:03 UTC -14.5186 14.5686 600000
FUSION PHARMACEUTICALS INC FUSN 2021-05-10 12:45:02 UTC -14.5186 14.5686 600000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments